DRMA | Dermata Therapeutics, Inc. Annual & Quarterly

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019
Revenue	-	-	-	-	-
Cost of Revenue	-	-	-	322.00	1355.00
Gross Profit	-	-	-	-322.00	-1355.00
Operating Expenses	8.04 Million	9.67 Million	7.85 Million	3.17 Million	4.47 Million
Selling, General and Administrative Expenses	3.97 Million	4.02 Million	4.39 Million	1.56 Million	1.84 Million
Research and Development Expenses	4.06 Million	5.65 Million	3.45 Million	1.6 Million	2.62 Million
Other Expenses	-	-	-	-	-
Cost and Expenses	8.04 Million	9.67 Million	7.85 Million	3.17 Million	4.47 Million
Operating Income	-8.04 Million	-9.67 Million	-7.85 Million	-3.17 Million	-4.47 Million
Interest Expense	-	-	45.61 Thousand	197.26 Thousand	250.74 Thousand
Income Tax Expense	-	-9674.49	45.61 Thousand	197.26 Thousand	250.74 Thousand
Earnings before Tax	-7.79 Million	-9.61 Million	-7.9 Million	-3.23 Million	-4.72 Million
Net Income	-7.79 Million	-9.61 Million	-7.94 Million	-3.43 Million	-4.97 Million
Earnings Per Share Basic	-40.18	-13.92	-15.27	-6.60	-9.55
Earnings Per Share Diluted	-39.98	-13.92	-15.27	-6.60	-9.55
Weighted Average Shares Outstanding	194 Thousand	690.66 Thousand	520.53 Thousand	520.53 Thousand	520.53 Thousand
Weighted Average Shares Outstanding (Diluted)	194.96 Thousand	690.66 Thousand	520.53 Thousand	520.53 Thousand	520.53 Thousand
Gross Margin	-	-	-	-	-
EBIT Margin	-	-	-	-	-
Profit Margin	-	-	-	-	-
EBITDA	247.21 Thousand	-	-7.85 Million	-3.17 Million	-4.46 Million
Earnings Before Tax Margin	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	2.88 Million	3.2 Million	2.21 Million	8.04 Million	1.81 Million	1.73 Million
Selling, General and Administrative Expenses	874.64 Thousand	1.6 Million	1.08 Million	-	909 Thousand	893.48 Thousand
Research and Development Expenses	2 Million	1.6 Million	1.13 Million	-	902.97 Thousand	838.93 Thousand
Other Expenses	-	-	-	-	-	-
Cost and Expenses	2.88 Million	3.2 Million	2.21 Million	8.04 Million	1.81 Million	1.73 Million
Operating Income	-2.88 Million	-3.2 Million	-2.21 Million	-8.04 Million	-1.81 Million	-1.73 Million
Interest Expense	-	-	37.54 Thousand	-	-	-
Income Tax Expense	-2.88 Million	-3.2 Million	-2219.83	-8041.91	-1811.98	-1732.41
Earnings before Tax	-2.82 Million	-3.13 Million	-2.13 Million	-7.79 Million	-1.71 Million	-1.7 Million
Net Income	-2.82 Million	-3.13 Million	-2.13 Million	-7.79 Million	-1.71 Million	-1.7 Million
Earnings Per Share Basic	-4.18	-7.06	-0.54	-	-0.54	-0.63
Earnings Per Share Diluted	-4.18	-7.06	-0.54	-	-0.54	-0.63
Weighted Average Shares Outstanding	676.56 Thousand	444.05 Thousand	3.93 Million	194.95 Thousand	3.18 Million	2.7 Million
Weighted Average Shares Outstanding (Diluted)	676.56 Thousand	444.05 Thousand	3.93 Million	194.95 Thousand	3.18 Million	2.7 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-2.88 Million	-3.2 Million	-2.21 Million	-	-1.81 Million	-1.73 Million
Earnings Before Tax Margin	-	-	-	-	-	-